Volume 66, Issue 5 , Pages 1335-1338, 1 December 2006
Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost
To access this article, please choose from the options below
J.S.V., M.B., and J.S.T. conceived the study.J.S.V., M.B., J.S.T., S.M., M.R., B.H., U.K., F.W., D.J., C.S., A.M.T., J.A.D. recruited and treated patients. J.S.V., M.B., J.S.T., S.M, M.R., B.H., U.K., F.W., D.J., C.S., A.M.T., J.A.D., E.H., and J.H. collected the data.M.K., R.S., M.D., and F.M. were involved in later follow-up care.J.S.V., O.M., S.M., U.K.T., T.C., and B.H. analyzed the data.J.S.V. and S.M. wrote the first draft and all other authors contributed to the final manuscript.
PII: S0360-3016(06)02754-4
doi:10.1016/j.ijrobp.2006.07.1378
© 2006 Elsevier Inc. All rights reserved.
Volume 66, Issue 5 , Pages 1335-1338, 1 December 2006
